It has been a mixed year for CorMedix Inc. insiders: $276,000 bought by one person and $2.6 million sold by four, so more selling than buying overall.
Biggest single buyer: Kaplan Myron, Director, with roughly $276,000.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. On the institutional side, 194 funds reported holding CRMD at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Dillione Janet | Director | Sell | 10,000 | $6.88 | $69K | SEC |
| Jan 2, 2026 | DUNTON ALAN W | Director | Sell | 20,000 | $13.00 | $260K | SEC |
| Dec 19, 2025 | Todisco Joseph | CEO | Sell | 30,000 | $12.00 | $360K | SEC |
| Dec 11, 2025 | Dillione Janet | Director | Sell | 34,000 | $12.00 | $408K | SEC |
| Dec 10, 2025 | Lefkowitz Steven W | Director | Sell | 40,000 | $11.88 | $475K | SEC |
| Dec 4, 2025 | Dillione Janet | Director | Sell | 46,657 | $10.00 | $467K | SEC |
| Nov 26, 2025 | Dillione Janet | Director | Sell | 26,343 | $9.93 | $262K | SEC |
| Nov 18, 2025 | Dillione Janet | Director | Sell | 30,000 | $11.42 | $343K | SEC |
| Oct 27, 2025 | Kaplan Myron | Director | Buy | 25,000 | $11.02 | $276K | SEC |
| Sep 16, 2025 | DUNTON ALAN W | Director | Sell | 10,000 | $13.13 | $131K | SEC |
| Sep 12, 2025 | Todisco Joseph | CEO | Sell | 50,000 | $13.00 | $650K | SEC |
| Sep 11, 2025 | Zelnick Kaufman Beth | Executive Officer | Sell | 49,600 | $13.41 | $665K | SEC |
| Sep 11, 2025 | Zelnick Kaufman Beth | Executive Officer | Sell | 400 | $12.82 | $5K | SEC |
| Sep 11, 2025 | Hurlburt Elizabeth | COO | Sell | 12,876 | $13.51 | $174K | SEC |
| Sep 11, 2025 | Hurlburt Elizabeth | COO | Sell | 41,121 | $13.08 | $538K | SEC |
In the last 12 months CorMedix Inc. insiders made open-market purchases worth about $276,000 and sales worth about $2.6 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CRMD was filed on 2026-01-22.
194 investment managers reported holding CRMD in SEC Form 13F filings for Q2 2026.
No congressional trades in CRMD were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).